1. Maamouri GA, Boskabadi H, Khatami F,Mohammadzadeh A, Saeidi R, Farhat A, et al.
Hyperbilirubinemia and neonatal infection. Int J Pediatr. 2014; 2(2.1):81.
2. Boskabadi H, Ghayour-Mobarhan M, Bagheri F,Pourbadakhshan N. The comparison of pro-oxidantantioxidant balance in physiologic and pathologic jaundice. Iran J Pediatr. 2020; 30(1):e98117.
3. Boskabadi H, Zakerihamidi M. The correlation between frequency and duration of breastfeeding and the severity of neonatal hyperbilirubinemia. J Matern Fetal Neonatal Med. 2018; 31(4):457-63.
4. Boskabadi H, Rakhshanizadeh F, Moradi A,Zakerihamidi M. Risk factors and causes of neonatal hyperbilirubinemia: a systematic review study. J Pediatr Rev. 2020; In Press.
5. Maamouri G, Boskabadi H, Mafinejad S, Bozorgnia Y,Khakshur A. Efficacy of oral zinc sulfate intake inprevention of neonatal jaundice. Iran J Neonatol.2014; 4(4):11-6.
6. Tamook A, Salehzadeh F, Aminisani N. Etiology of neonatal hyperbilirubinemia at Ardabil Sabalanhospital, 2003. J Ardabil Univ Med Sci. 2005;5(4):316-20.
7. Behjati S, Sagheb S, Aryasepehr S, Yaghmai B.Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr.2009; 76(1):83-5.
8. Heydarian F, Majdi M. Severe neonatal hyperbilirubinemia;causes and contributing factorsleading to exchange transfusion at Ghaem Hospital in Mashhad. Acta Med Iran. 2010; 48(6):399-402.
9. Saber A, Ferdowsi S, Askari F, Farsi L. Epidemiology of pathological jaundice and its association with demographic factors in infants born in the 22 Bahman Hospital in Gonabad, 2011. Razi J Med Sci.2013; 20(114):42-8.
10. National Collaborating Centre for Women's and Children's Health (UK. Early prediction of serious hyperbilirubinaemia). London: RCOG Press; 2010.
11. Bülbül A, Okan Ff, Ünsür Ek, Nuhoğlu A. Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns. Turk J Med Sci. 2011; 41(1):
93-100.
12. Zarrinkoub F, Beigi A. Epidemiology of hyperbilirubinemia in the first 24 hours after birth.Tehran Univ Med J. 2007; 65(6):54-9.
13. Boskabadi H, Zakerihamidi M, Bagheri F. Outcomes of vaginal delivery and cesarean in Mashhad Ghaem University Hospital. Tehran Univ Med J. 2014;71(12):807-15.
14. Boskabadi H, Navaei M. Relationship between delivery type and jaundice severity among
newborns referred to Ghaem Hospital within a 6year period in Mashhad. Iran J Obstet Gynecol Infertil. 2011; 14(4):15-21.
15. Boskabadi H, Zakerihamidi M, Bagheri F. A comparison of the characteristics of neonates born by normal vaginal deliveries and cesarean sections. J Obstet Gynecol Cancer Res. 2019; 4(3):93-8.
16. Boskabadi H, Maamouri G, Bagheri S. Significant neonatal weight loss related to idiopathic neonatal hyperbilirubinemia. Int J Pediatr. 2014; 2(4.1):225-31.
17. Salas AA, Mazzi E. Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country. Acta Paediatr. 2008;97(6):754-8.
18. Davutoğlu M, Garipardiç M, Güler E, Karabiber H,Erhan D. The etiology of severe neonatal
hyperbilirubinemia and complications of exchange transfusion. Turk J Pediatr. 2010; 52(2):163-6.
19. Boskabadi H, Ashrafzadeh F, Azarkish F, Khakshour A. Complications of neonatal jaundice and the predisposing factors in newborns. J Babol Univ Med Sci. 2015; 17(9):7-13.
20. Boskabadi H, Maamouri G, Mafinejad S,Rezagholizadeh F. Clinical course and prognosis of
hemolytic jaundice in neonates in North East of Iran.Macedonian J Med Sci. 2011; 4(4):403-7.
21. Badiee Z. Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan, Iran.Singapore Med J. 2007; 48(5):421.
22. Cheng SW, Chiu YW, Weng YH. Etiological analyses of marked neonatal hyperbilirubinemia in a single institution in Taiwan. Chang Gung Med J. 2012;35(2):148-54.
23. Boskabadi H, Zakerihamidi M, Bagheri F. Frequency of major and minor risk factors associated with jaundice in hospitalized newborns. Tehran Univ Med J. 2017; 75(2):141-51.